Truist Financial reissued their buy rating on shares of American Healthcare REIT (NYSE:AHR – Free Report) in a report issued on Monday morning, Benzinga reports. The brokerage currently has a $17.00 price target on the stock.
Several other equities analysts also recently issued reports on AHR. Morgan Stanley began coverage on shares of American Healthcare REIT in a research note on Monday, March 4th. They set an overweight rating and a $17.00 price objective on the stock. Barclays began coverage on shares of American Healthcare REIT in a research note on Thursday, March 14th. They set an overweight rating and a $18.00 price objective on the stock. Citigroup began coverage on shares of American Healthcare REIT in a research note on Monday, March 4th. They set a neutral rating and a $14.00 price objective on the stock. Bank of America began coverage on shares of American Healthcare REIT in a research note on Monday, March 4th. They set a buy rating and a $15.00 price objective on the stock. Finally, JMP Securities reissued a market outperform rating and set a $16.00 price objective on shares of American Healthcare REIT in a research note on Monday. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of Moderate Buy and a consensus target price of $16.00.
Check Out Our Latest Report on American Healthcare REIT
American Healthcare REIT Stock Performance
American Healthcare REIT Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, April 19th. Investors of record on Thursday, March 28th will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 6.78%. The ex-dividend date is Wednesday, March 27th.
Insider Buying and Selling
In other American Healthcare REIT news, Director Mathieu B. Streiff acquired 83,333 shares of the company’s stock in a transaction dated Friday, February 9th. The stock was bought at an average price of $12.00 per share, with a total value of $999,996.00. Following the completion of the transaction, the director now directly owns 90,740 shares of the company’s stock, valued at $1,088,880. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
American Healthcare REIT Company Profile
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Featured Stories
- Five stocks we like better than American Healthcare REIT
- How to invest in marijuana stocks in 7 stepsÂ
- 3 Value Stocks Too Small For Buffett’s Portfolio
- What is the Australian Securities Exchange (ASX)
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- Stock Analyst Ratings and Canadian Analyst Ratings
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.